ID   SIG10_MOUSE             Reviewed;         688 AA.
AC   Q80ZE3;
DT   30-AUG-2017, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2003, sequence version 1.
DT   03-AUG-2022, entry version 151.
DE   RecName: Full=Sialic acid-binding Ig-like lectin 10;
DE            Short=Siglec-10;
DE   AltName: Full=Sialic acid-binding Ig-like lectin G;
DE            Short=Siglec-G;
DE            Short=mSiglec-G;
DE   Flags: Precursor;
GN   Name=Siglec10; Synonyms=Siglecg;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=BALB/cJ;
RX   PubMed=14559209; DOI=10.1016/s0888-7543(03)00171-x;
RA   Aizawa H., Zimmermann N., Carrigan P.E., Lee J.J., Rothenberg M.E.,
RA   Bochner B.S.;
RT   "Molecular analysis of human Siglec-8 orthologs relevant to mouse
RT   eosinophils: identification of mouse orthologs of Siglec-5 (mSiglec-F) and
RT   Siglec-10 (mSiglec-G).";
RL   Genomics 82:521-530(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [3]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=17572677; DOI=10.1038/ni1480;
RA   Hoffmann A., Kerr S., Jellusova J., Zhang J., Weisel F., Wellmann U.,
RA   Winkler T.H., Kneitz B., Crocker P.R., Nitschke L.;
RT   "Siglec-G is a B1 cell-inhibitory receptor that controls expansion and
RT   calcium signaling of the B1 cell population.";
RL   Nat. Immunol. 8:695-704(2007).
RN   [4]
RP   FUNCTION, AND INTERACTION WITH CD24 AND HMGB1.
RX   PubMed=19264983; DOI=10.1126/science.1168988;
RA   Chen G.Y., Tang J., Zheng P., Liu Y.;
RT   "CD24 and Siglec-10 selectively repress tissue damage-induced immune
RT   responses.";
RL   Science 323:1722-1725(2009).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Spleen;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [6]
RP   FUNCTION.
RX   PubMed=20038598; DOI=10.1084/jem.20091873;
RA   Duong B.H., Tian H., Ota T., Completo G., Han S., Vela J.L., Ota M.,
RA   Kubitz M., Bovin N., Paulson J.C., Paulson J., Nemazee D.;
RT   "Decoration of T-independent antigen with ligands for CD22 and Siglec-G can
RT   suppress immunity and induce B cell tolerance in vivo.";
RL   J. Exp. Med. 207:173-187(2010).
RN   [7]
RP   FUNCTION.
RX   PubMed=23836061; DOI=10.4049/jimmunol.1300921;
RA   Pfrengle F., Macauley M.S., Kawasaki N., Paulson J.C.;
RT   "Copresentation of antigen and ligands of Siglec-G induces B cell tolerance
RT   independent of CD22.";
RL   J. Immunol. 191:1724-1731(2013).
RN   [8]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=20200274; DOI=10.4049/jimmunol.0902711;
RA   Jellusova J., Wellmann U., Amann K., Winkler T.H., Nitschke L.;
RT   "CD22 x Siglec-G double-deficient mice have massively increased B1 cell
RT   numbers and develop systemic autoimmunity.";
RL   J. Immunol. 184:3618-3627(2010).
RN   [9]
RP   FUNCTION, INTERACTION WITH DDX58; CBL AND PTPN11, AND MUTAGENESIS OF
RP   TYR-590; TYR-635; TYR-659 AND TYR-682.
RX   PubMed=23374343; DOI=10.1016/j.cell.2013.01.011;
RA   Chen W., Han C., Xie B., Hu X., Yu Q., Shi L., Wang Q., Li D., Wang J.,
RA   Zheng P., Liu Y., Cao X.;
RT   "Induction of Siglec-G by RNA viruses inhibits the innate immune response
RT   by promoting RIG-I degradation.";
RL   Cell 152:467-478(2013).
RN   [10]
RP   FUNCTION, MUTAGENESIS OF ARG-120, AND SUBUNIT.
RX   PubMed=24790146; DOI=10.4049/jimmunol.1302875;
RA   Hutzler S., Oezgoer L., Naito-Matsui Y., Klaesener K., Winkler T.H.,
RA   Reth M., Nitschke L.;
RT   "The ligand-binding domain of Siglec-G is crucial for its selective
RT   inhibitory function on B1 cells.";
RL   J. Immunol. 192:5406-5414(2014).
RN   [11]
RP   FUNCTION, AND INTERACTION WITH PTPN6 AND NCF1.
RX   PubMed=27548433; DOI=10.1038/ni.3535;
RA   Ding Y., Guo Z., Liu Y., Li X., Zhang Q., Xu X., Gu Y., Zhang Y., Zhao D.,
RA   Cao X.;
RT   "The lectin Siglec-G inhibits dendritic cell cross-presentation by
RT   impairing MHC class I-peptide complex formation.";
RL   Nat. Immunol. 17:1167-1175(2016).
CC   -!- FUNCTION: Putative adhesion molecule that mediates sialic-acid
CC       dependent binding to cells. Preferentially binds to alpha-2,3- or
CC       alpha-2,6-linked sialic acid (PubMed:20038598). The sialic acid
CC       recognition site may be masked by cis interactions with sialic acids on
CC       the same cell surface. In the immune response, seems to act as an
CC       inhibitory receptor upon ligand induced tyrosine phosphorylation by
CC       recruiting cytoplasmic phosphatase(s) via their SH2 domain(s) that
CC       block signal transduction through dephosphorylation of signaling
CC       molecules (By similarity). Involved in negative regulation of B-cell
CC       antigen receptor signaling and specifically acts on B1 cells to inhibit
CC       Ca(2+) signaling, cellular expansion and antibody secretion
CC       (PubMed:17572677). The inhibition of B cell activation is dependent on
CC       PTPN6/SHP-1 (PubMed:23836061). In association with CD24 may be involved
CC       in the selective suppression of the immune response to danger-
CC       associated molecular patterns (DAMPs) such as HMGB1, HSP70 and HSP90
CC       (PubMed:19264983). In association with CD24 may regulate the immune
CC       repsonse of natural killer (NK) cells (By similarity). Plays a role in
CC       the control of autoimmunity (PubMed:20200274). During initiation of
CC       adaptive immune responses by CD8-alpha(+) dendritic cells inhibits
CC       cross-presentation by impairing the formation of MHC class I-peptide
CC       complexes. The function seems to implicate recruitment of PTPN6/SHP-1,
CC       which dephosphorylates NCF1 of the NADPH oxidase complex consequently
CC       promoting phagosomal acidification (PubMed:27548433).
CC       {ECO:0000250|UniProtKB:Q96LC7, ECO:0000269|PubMed:17572677,
CC       ECO:0000269|PubMed:19264983, ECO:0000269|PubMed:20038598,
CC       ECO:0000269|PubMed:20200274, ECO:0000269|PubMed:27548433}.
CC   -!- FUNCTION: (Microbial infection) During infection by RNA viruses
CC       inhibits DDX58/RIG-I signaling in macrophages by promoting its CBL-
CC       dependent ubiquitination and degradation via PTPN11/SHP-2.
CC       {ECO:0000269|PubMed:23374343}.
CC   -!- SUBUNIT: Interacts with PTPN6/SHP-1 upon phosphorylation. Interacts
CC       with NCF1 (PubMed:27548433). Interacts with CD24; the probable
CC       CD24:SIGLEC10 complex is proposed to inhibit HGMB1-mediated tissue
CC       damage immune response. Interacts with HMGB1; the interaction is
CC       dependent on CD24 (PubMed:19264983). Associates with membrane IgM on
CC       the B cell surface (PubMed:24790146). Interacts with DDX58, CBL and
CC       PTPN11 (PubMed:23374343). {ECO:0000250|UniProtKB:Q96LC7,
CC       ECO:0000269|PubMed:19264983, ECO:0000269|PubMed:23374343,
CC       ECO:0000269|PubMed:24790146, ECO:0000269|PubMed:27548433}.
CC   -!- INTERACTION:
CC       Q80ZE3; Q6Q899: Ddx58; NbExp=7; IntAct=EBI-6841023, EBI-6841237;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:Q96LC7};
CC       Single-pass type I membrane protein.
CC   -!- TISSUE SPECIFICITY: Expressed in B cells with high levels in pre-B
CC       cells and B1a cells of the peritoneal cavity.
CC       {ECO:0000269|PubMed:17572677}.
CC   -!- DOMAIN: Contains 1 copy of a cytoplasmic motif that is referred to as
CC       the immunoreceptor tyrosine-based inhibitor motif (ITIM). This motif is
CC       involved in modulation of cellular responses. The phosphorylated ITIM
CC       motif can bind the SH2 domain of several SH2-containing phosphatases.
CC   -!- PTM: Phosphorylation of Tyr-659 is involved in binding to PTPN6.
CC       {ECO:0000250|UniProtKB:Q96LC7}.
CC   -!- DISRUPTION PHENOTYPE: Cd22/Siglec10 double-deficient mice develop
CC       autoimmune disease, which is not observed in single-deficient mice.
CC       {ECO:0000269|PubMed:20200274}.
CC   -!- SIMILARITY: Belongs to the immunoglobulin superfamily. SIGLEC (sialic
CC       acid binding Ig-like lectin) family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY210400; AAO48273.1; -; mRNA.
DR   EMBL; AC149091; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS52221.1; -.
DR   RefSeq; NP_766488.2; NM_172900.3.
DR   AlphaFoldDB; Q80ZE3; -.
DR   SMR; Q80ZE3; -.
DR   IntAct; Q80ZE3; 5.
DR   STRING; 10090.ENSMUSP00000005592; -.
DR   GlyGen; Q80ZE3; 2 sites.
DR   iPTMnet; Q80ZE3; -.
DR   PhosphoSitePlus; Q80ZE3; -.
DR   MaxQB; Q80ZE3; -.
DR   PaxDb; Q80ZE3; -.
DR   PRIDE; Q80ZE3; -.
DR   ProteomicsDB; 257177; -.
DR   DNASU; 243958; -.
DR   Ensembl; ENSMUST00000005592; ENSMUSP00000005592; ENSMUSG00000030468.
DR   GeneID; 243958; -.
DR   KEGG; mmu:243958; -.
DR   UCSC; uc009gmo.1; mouse.
DR   CTD; 243958; -.
DR   MGI; MGI:2443630; Siglecg.
DR   VEuPathDB; HostDB:ENSMUSG00000030468; -.
DR   eggNOG; ENOG502S41V; Eukaryota.
DR   GeneTree; ENSGT01040000240469; -.
DR   HOGENOM; CLU_024444_5_1_1; -.
DR   InParanoid; Q80ZE3; -.
DR   OMA; CEAWNTH; -.
DR   OrthoDB; 1124645at2759; -.
DR   PhylomeDB; Q80ZE3; -.
DR   TreeFam; TF332441; -.
DR   Reactome; R-MMU-198933; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell.
DR   Reactome; R-MMU-2172127; DAP12 interactions.
DR   BioGRID-ORCS; 243958; 1 hit in 72 CRISPR screens.
DR   ChiTaRS; Siglecg; mouse.
DR   PRO; PR:Q80ZE3; -.
DR   Proteomes; UP000000589; Chromosome 7.
DR   RNAct; Q80ZE3; protein.
DR   Bgee; ENSMUSG00000030468; Expressed in mesenteric lymph node and 43 other tissues.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; ISO:MGI.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:UniProtKB-KW.
DR   GO; GO:0019902; F:phosphatase binding; ISO:MGI.
DR   GO; GO:0042169; F:SH2 domain binding; ISO:MGI.
DR   GO; GO:0033691; F:sialic acid binding; ISO:MGI.
DR   GO; GO:0002250; P:adaptive immune response; IEA:UniProtKB-KW.
DR   GO; GO:0007155; P:cell adhesion; IBA:GO_Central.
DR   GO; GO:0002244; P:hematopoietic progenitor cell differentiation; IMP:MGI.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   GO; GO:0050849; P:negative regulation of calcium-mediated signaling; IGI:ARUK-UCL.
DR   GO; GO:0002638; P:negative regulation of immunoglobulin production; IGI:ARUK-UCL.
DR   GO; GO:0106015; P:negative regulation of inflammatory response to wounding; IPI:UniProtKB.
DR   GO; GO:0030888; P:regulation of B cell proliferation; IMP:ARUK-UCL.
DR   GO; GO:0050776; P:regulation of immune response; IGI:ARUK-UCL.
DR   Gene3D; 2.60.40.10; -; 4.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR013106; Ig_V-set.
DR   Pfam; PF07679; I-set; 1.
DR   Pfam; PF07686; V-set; 1.
DR   SMART; SM00409; IG; 4.
DR   SMART; SM00408; IGc2; 2.
DR   SUPFAM; SSF48726; SSF48726; 4.
DR   PROSITE; PS50835; IG_LIKE; 3.
PE   1: Evidence at protein level;
KW   Adaptive immunity; Cell adhesion; Cell membrane; Disulfide bond;
KW   Glycoprotein; Immunity; Immunoglobulin domain; Innate immunity; Lectin;
KW   Membrane; Phosphoprotein; Reference proteome; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL          1..17
FT                   /evidence="ECO:0000255"
FT   CHAIN           18..688
FT                   /note="Sialic acid-binding Ig-like lectin 10"
FT                   /evidence="ECO:0000255"
FT                   /id="PRO_5010508953"
FT   TOPO_DOM        18..543
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        544..564
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        565..688
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          26..138
FT                   /note="Ig-like V-type"
FT   DOMAIN          145..228
FT                   /note="Ig-like C2-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DOMAIN          250..334
FT                   /note="Ig-like C2-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DOMAIN          339..436
FT                   /note="Ig-like C2-type 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   REGION          602..656
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           588..593
FT                   /note="ITIM motif 1"
FT                   /evidence="ECO:0000250|UniProtKB:Q96LC7"
FT   MOTIF           657..662
FT                   /note="ITIM motif 2"
FT                   /evidence="ECO:0000250|UniProtKB:Q96LC7"
FT   COMPBIAS        619..633
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        638..652
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         120
FT                   /ligand="N-acetylneuraminate"
FT                   /ligand_id="ChEBI:CHEBI:35418"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         659
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96LC7"
FT   CARBOHYD        195
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        246
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        37..172
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        42..102
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        163..214
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        271..318
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        375..420
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   MUTAGEN         120
FT                   /note="R->E: Decreases interaction with membrane IgM (with
FT                   greater effect in B1a than in B2 cells)."
FT                   /evidence="ECO:0000269|PubMed:24790146"
FT   MUTAGEN         590
FT                   /note="Y->F: Decreases interaction with DDX58; when
FT                   associated with F-635, F-659 and F-682."
FT                   /evidence="ECO:0000269|PubMed:23374343"
FT   MUTAGEN         635
FT                   /note="Y->F: Decreases interaction with DDX58; when
FT                   associated with F-590, F-659 and F-682."
FT                   /evidence="ECO:0000269|PubMed:23374343"
FT   MUTAGEN         659
FT                   /note="Y->F: Decreases interaction with DDX58; when
FT                   associated with F-590,F-635 and F-682."
FT                   /evidence="ECO:0000269|PubMed:23374343"
FT   MUTAGEN         682
FT                   /note="Y->F: Decreases interaction with DDX58; when
FT                   associated with F-590, F-635 and F-659."
FT                   /evidence="ECO:0000269|PubMed:23374343"
SQ   SEQUENCE   688 AA;  76884 MW;  21A619E1500BFA76 CRC64;
     MSLLLFLLSF LLDGPQGQME SYFLQVQRIV KAQEGLCIFV PCSFSSPEGK WLNRSPLYGY
     WFKGIRKPSL SFPVATNNKD KVLEWEARGR FQLLGDISKK NCSLLIKDVQ WGDSTNYFFR
     MERGFERFSF KEEFRLQVEA LTQKPDIFIP EVLEPGEPVT VVCLFSWTFN QCPAPSFSWM
     GDAVSFQESR PHTSNYSVLS FIPGLQHHDT ELTCQLDFSR MSTQRTVRLR VAYAPRSLAI
     SIFHDNVSVP DLHENPSHLE VQQGQSLRLL CTADSQPPAT LSWVLEDQVL SWSSPVGSRT
     LALELPWVKA GDSGHYTCQA ENRLGSQQHT LDLSVLYPPQ DLRVTVSQAN RTVLEILRNA
     ISLPVLEGQS LCLVCVTYSN PPANVSWAWV TQTLIPIQSS EPGVLELPLV QREHEGEFTC
     AAQNPLGAQR ISLSLSVHYP PQMSSPSCSW EAKGLHCNCS SRAWPAPSLR WRLGEGLLEG
     NSSNASFTVT FSSLGPWVNS SLSLLQELGP SLWLSCESWN THGAQTTSVL LLPDKDSATA
     FSKGAVLGFG ITALLALCLI VVIVKTLQKK GTQEEPSRPK LSRGSTILDY INVVPKTRSL
     ARNWKAEPDA PSRSSPLDTH FPKPKKKQKD PHFTYPGCPD PTSSSQVPVS ENNPEELHYA
     ALNFSRLRLQ ETQDPQDTYS DYTEVRVH
//
